Moderna (MRNA)
(Delayed Data from NSDQ)
$107.97 USD
+1.79 (1.69%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $107.85 -0.12 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Earnings News For MRNA
-
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
-
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
-
Moderna (MRNA) Q4 Earnings and Revenues Beat Estimates
-
Moderna: Q4 Earnings Snapshot
-
Moderna: Q4 Earnings Snapshot
-
Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates?
-
Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy?
-
Moderna (MRNA) Beats on Q3 Earnings & Sales, Expects Lower COVID Demand
-
Moderna: Q3 Earnings Snapshot
-
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
-
Moderna (MRNA) to Report Q3 Earnings: What's in the Cards?
-
Moderna (MRNA) Beats on Q2 Earnings & Sales, Raises '23 View
-
Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates
-
Moderna (MRNA) to Report Q2 Earnings: Will It Beat Estimates?
-
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
-
Moderna (MRNA) Q1 Earnings and Revenues Beat Estimates
-
Moderna: Q1 Earnings Snapshot
-
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?
-
Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy?
-
Moderna (MRNA) Lags on Q4 Earnings, COVID Jab Sales Down Y/Y
-
Moderna (MRNA) Lags Q4 Earnings and Revenue Estimates
-
Moderna: Q4 Earnings Snapshot
-
Moderna (MRNA) to Report Q4 Earnings: What's in the Cards?
-
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
-
Moderna's (MRNA) Lags on Q3 Earnings, Lowers '22 Sales Outlook